Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

782 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.
Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Zimmermann J, et al. Among authors: wanner c. Kidney Int. 1999 Feb;55(2):648-58. doi: 10.1046/j.1523-1755.1999.00273.x. Kidney Int. 1999. PMID: 9987089
Importance of hyperlipidaemia and therapy in renal patients.
Wanner C. Wanner C. Nephrol Dial Transplant. 2000;15 Suppl 5:92-6. doi: 10.1093/ndt/15.suppl_5.92. Nephrol Dial Transplant. 2000. PMID: 11073280 Review. No abstract available.
Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship?
Schwedler S, Schinzel R, Vaith P, Wanner C. Schwedler S, et al. Among authors: wanner c. Kidney Int Suppl. 2001 Feb;78:S32-6. doi: 10.1046/j.1523-1755.2001.59780032.x. Kidney Int Suppl. 2001. PMID: 11168979 Review.
Modification of lipoproteins in uremia: oxidation, glycation and carbamoylation.
Galle J, Wanner C. Galle J, et al. Among authors: wanner c. Miner Electrolyte Metab. 1999 Jul-Dec;25(4-6):263-8. doi: 10.1159/000057458. Miner Electrolyte Metab. 1999. PMID: 10681650 Review.
Immunosuppression enhances atherogenicity of lipid profile after transplantation.
Quaschning T, Mainka T, Nauck M, Rump LC, Wanner C, Krämer-Guth A. Quaschning T, et al. Among authors: wanner c. Kidney Int Suppl. 1999 Jul;71:S235-7. doi: 10.1046/j.1523-1755.1999.07162.x. Kidney Int Suppl. 1999. PMID: 10412786 Clinical Trial.
Smoking as a risk factor for end-stage renal failure in men with primary renal disease.
Orth SR, Stöckmann A, Conradt C, Ritz E, Ferro M, Kreusser W, Piccoli G, Rambausek M, Roccatello D, Schäfer K, Sieberth HG, Wanner C, Watschinger B, Zucchelli P. Orth SR, et al. Among authors: wanner c. Kidney Int. 1998 Sep;54(3):926-31. doi: 10.1046/j.1523-1755.1998.00067.x. Kidney Int. 1998. PMID: 9734618
Causes of coronary heart disease in patients on renal replacement therapy.
Wanner C, Zimmermann J. Wanner C, et al. Kidney Blood Press Res. 1998;21(2-4):287-9. doi: 10.1159/000025881. Kidney Blood Press Res. 1998. PMID: 9762860 Review. No abstract available.
Simvastatin in nephrotic syndrome. Simvastatin in Nephrotic Syndrome Study Group.
Olbricht CJ, Wanner C, Thiery J, Basten A. Olbricht CJ, et al. Among authors: wanner c. Kidney Int Suppl. 1999 Jul;71:S113-6. doi: 10.1046/j.1523-1755.1999.07128.x. Kidney Int Suppl. 1999. PMID: 10412752
Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators.
Wanner C, Krane V, Ruf G, März W, Ritz E. Wanner C, et al. Kidney Int Suppl. 1999 Jul;71:S222-6. doi: 10.1046/j.1523-1755.1999.07158.x. Kidney Int Suppl. 1999. PMID: 10412782
Abnormal lipid metabolism after renal transplantation.
Wanner C, Quaschning T. Wanner C, et al. Ann Transplant. 2001;6(1):5-8. Ann Transplant. 2001. PMID: 11803608 Review.
782 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page